title: [Investigation of Evolution Rules of Phlegm and Blood Stasis Syndrome in Hyperlipidemia and Ath- erosclerosis by NMR-based Metabolic Profiling and Metabonomic Approaches].
abstract: OBJECTIVE
  To explore evolution rules of phlegm and blood stasis syndrome ( PBSS) in hyperlipidemia and atherosclerosis (AS) using NMR-based metabolic profiling and metabonomic approaches based on formulas corresponding to syndrome.
  
  
  METHODS
  Totally 150 SD rats were divided into the normal group, the model group, the Erchen Decoction (ED) group, the Xuefu Zhuyu Decoction (XZD) group, the Lipitor group, 30 in each group. The hyperlipidemia and AS rat model was duplicated by suturing carotid artery, injecting vitamin D3, and feeding with high fat diet. ED and XZD were used as drug probes. Blood samples were withdrawn at week 2, 4, and 8 after modeling. Blood lipids, blood rheology, histopathology and metabolomics were detected and analyzed. Results Results of blood lipids and pathology showed hyperlipidemia and early AS rat models were successfully established. At week 2 after modeling, levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) significantly increased, which reached the peak at week 4 and maintained at higher levels at week 8. ED exerted obvious effect in improving TC and LDL-C levels of early models, while XZD could greatly improve levels of TC and LDL-C of late models. Rheological results showed at week 2, there was no significant difference in whole blood viscosity, plasma viscosity, or hematocrit between the model group and the normal group (P > 0.05). At week 4 partial hemorheological indicators (such as plasma viscosity) were abnormal. Till week 8 whole blood viscosity, plasma viscosity, and hematocrit were significantly abnormal (P <0. 05, P < 0.01). As time went by, whole blood viscosity, plasma viscosity, and hematocrit showed gradual increasing tendency in the ED group, while they showed gradual decreasing tendency in the XZD group. Results of metabonomics showed significant difference in spectra of metabolites between the normal group and the model group. As modeling time was prolonged, contents of acetyl glucoprotein and glucose in the model group increased in late stage, which was in. line with results of blood lipids and hemorheology. ED showed more obvious effect in early and mid-term modeling (at week 2 and 4), and increased contents of partial metabolites (such as choline, phosphatidyl choline, glycerophosphocholine), but these changes in the XZD group were consistent with those of the model group. In late modeling (at week 8) XZD showed more obvious effect in improving contents of lactic acid, acetyl glycoprotein, LDL, creatine, choline, and glucose.
  
  
  CONCLUSIONS
  ED and XZD not only showed regulatory effects on lipid disorders, but also could improve dysbolism of Chos. In formulas corresponding to syndrome, damp-phlegm was main pathogenesis of hyperlipidema and AS in early and mid stages. Blood stasis syndrome began to occur along with it progressed. Phlegm can result in blood stasis and intermingles with stasis. Phlegm turbidity runs through the whole process.
authors.forename: Lei
authors.initials: L
authors.lastname: Zhang
authors.forename: Qi
authors.initials: Q
authors.lastname: Zhang
authors.forename: Yun
authors.initials: Y
authors.lastname: You
authors.forename: Ming-xue
authors.initials: MX
authors.lastname: Zhou
authors.forename: Li-hua
authors.initials: LH
authors.lastname: Wang
authors.forename: He-bing
authors.initials: HB
authors.lastname: Chen
authors.forename: Xian-zhong
authors.initials: XZ
authors.lastname: Yan
authors.forename: Xian-zhong
authors.initials: XZ
authors.lastname: Liu
authors.forename: Wei-hong
authors.initials: WH
authors.lastname: Liu
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000378:metabolism*; D002784:Cholesterol; D008078:Cholesterol, LDL; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D018056:Hemorheology; D006949:Hyperlipidemias; D008055:Lipids; D008279:Magnetic Resonance Imaging; D008516:Medicine, Chinese Traditional; D055442:Metabolome / Q000502:physiology*; D055432:Metabolomics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013183:Sputum / Q000378:metabolism*
chemical_list: D008078:Cholesterol, LDL; D004365:Drugs, Chinese Herbal; D008055:Lipids; C513826:Xue-Fu-Zhu-Yu decoction; D002784:Cholesterol